4//SEC Filing
Kennedy Eugene P. 4
Accession 0001126234-20-000045
CIK 0001126234other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 6:21 PM ET
Size
7.7 KB
Accession
0001126234-20-000045
Insider Transaction Report
Form 4
LUMOS PHARMA, INC.(LUMO)
Kennedy Eugene P.
Chief Medical Officer
Transactions
- Award
Common Stock
2020-04-01+9,000→ 10,484 total - Award
Stock Option (Right to Buy)
2020-04-01+45,000→ 45,000 totalExercise: $7.87Exp: 2030-03-31→ Common Stock (45,000 underlying)
Footnotes (2)
- [F1]Represents shares issued as restricted stock units ("RSUs") under the Issuer's 2009 Equity Incentive Plan, as amended, (the "Plan") that were received as an award, for no consideration. The RSUs vest in a series of four successive annual installments beginning on April 1, 2021, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
- [F2]Grant to the Reporting Person of a stock option under the Plan. The option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on May 1, 2020, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan. The option expires ten years after the date of grant.
Documents
Issuer
LUMOS PHARMA, INC.
CIK 0001126234
Entity typeother
Related Parties
1- filerCIK 0001721685
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 6:21 PM ET
- Size
- 7.7 KB